Company: SCLXW
Filing Date: 2025-10-28
Form Type: PRE 14A
Source: 0001193125-25-253884
Chunk: 19

Company: Scilex Holding Co
Filing Date: 2025-10-28
Form: PRE 14A
Chunk 19
---
 2022 Plan. If any shares of our Common Stock issued pursuant to an award are forfeited back to or repurchased or reacquired by us (i) because of a failure to meet a contingency or condition           
 required for the vesting of such shares; (ii) to satisfy the exercise, strike or purchase price of an award; or (iii) to satisfy a tax withholding obligation in connection with an award, the shares that are forfeited or repurchased or                
 reacquired will revert to and again become available for issuance under the 2022 Plan. The Company no longer makes grants under the 2017 Plan or the 2019 Plan.                                                                                           |

12

| (5) | As of December 31, 2024, a total of 118,350 shares of our Common Stock have been reserved for future                                                                                                                                             
 issuance pursuant to the ESPP, which number excludes the 52,223 shares that were added to the ESPP as a result of the automatic annual increase on January 1, 2025. The ESPP provides that the number of shares of our Common Stock reserved and 
 available for issuance under the ESPP will automatically increase on January 1 of each year for a period of up to 10 years, commencing on January 1, 2023 and ending on (and including) January 1, 2032, in an amount equal to the lesser        
 of (A) 1% of the total number of shares of our Common Stock outstanding on December 31 of the immediately preceding calendar year, (B) 52,223 shares of our Common Stock (subject to the adjustment for recapitalizations, stock splits, stock   
 dividends and similar transactions), and (C) such number of shares of our Common Stock determined by our Board or our Compensation Committee prior to January 1 of a given year, provided however, that our Board may act prior to               
 January 1 of a given calendar year to provide that there will be no increase for such calendar year or the increase for such year will be a lesser number of shares than the amount set forth in clauses (A) to (C) above.                       |

Interests of Certain Persons in the Option Repricing The following table sets forth certain information as of October 17, 2025 regarding the outstanding Eligible Options (i.e., those options granted under the 2022 Plan with an exercise price of $282.80 per share) for the Option Repricing held by our current named executive officers